论文信息 - Evaluation of Cost-Effectiveness of Adjuvant Osimertinib in Patients with Resected EGFR Mutation-Positive Non-small Cell Lung Cancer - 字舞流文

Evaluation of Cost-Effectiveness of Adjuvant Osimertinib in Patients with Resected EGFR Mutation-Positive Non-small Cell Lung Cancer

F. Shepherd | F. de Marinis | T. John | B. Melosky | B. Heeg | P. Cheema | B. Samson | A. Verhoek | D. Moldaver | Yi‐Long Wu | M. Miranda | Benjamin Bracke | Nadia Van Dalfsen | Simon Shaw | B. Bracke